Given the key role of the ANG family in angiogenesis and tumor metastasis, it is expected that ANG-targeted drugs with low side-effects will be developed in the future to achieve precision treatment of oral tumors, enhance therapeutic efficacy, reduce recurrence and metastasis, and improve the quality of life of patients. Here, ANG is linked to neoplasm.